ClinVar Miner

Submissions for variant NM_182961.4(SYNE1):c.17816_17820del (p.Asp5939fs)

dbSNP: rs794727986
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000180749 SCV000233235 pathogenic not provided 2016-02-02 criteria provided, single submitter clinical testing
Ambry Genetics RCV001266189 SCV001444361 pathogenic Inborn genetic diseases 2018-03-09 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003390903 SCV004121224 pathogenic SYNE1-related condition 2022-11-15 criteria provided, single submitter clinical testing The SYNE1 c.17603_17607del5 variant is predicted to result in a frameshift and premature protein termination (p.Asp5868Alafs*13). This variant has been reported in a family with cerebellar ataxia (Reported as 334338-334342delATTTG in Gros-Louis et al 2007. PubMed ID: 17159980). This variant is reported in 0.0023% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-152615124-GCAAAT-G). Frameshift variants in SYNE1 are expected to be pathogenic. This variant is interpreted as pathogenic.
OMIM RCV002271991 SCV000022576 pathogenic Autosomal recessive ataxia, Beauce type 2007-01-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.